Even though the vaccine-induced GagCM9-specific CD8+ T cells in our current study expanded to high frequencies by two weeks post-SIVsmE660 infection, the SIV-specific CD8+ T cell response may have simply arrived too late to control viral replication and prevent CD4+ T cell loss in the gut mucosa. Here, CD8A is linked to infection.